home / stock / accd / accd articles
Coverage for obesity medications, including Novo Nordisk A/S's (NYSE: NVO) Wegovy, is expected to expand among U.S. employers, accord...
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin...
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares rose 95.5% to $15.80 in pre-market trading after the company inked a deal with Kyowa Kirin...
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Wall Street ...
Accolade, Inc. (NASDAQ: ACCD) shares are trading lower after-hours on Wednesday after the company announced results for the second-quarter 2024 and...
Accolade, Inc. (NASDAQ: ACCD) is expected to release financial results for its fiscal second quarter 2024 after the closing bell on Oct. 4, 2023. A...
On Monday, Cathie Wood-led Ark Invest made a significant move by continuing its buying spree of Archer Aviation Inc (NASDAQ:ACHR) shares. The inve...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 50.0% to $0.495 on volume of 360,218,139 shares NVIDIA Corporation (NVDA) fell 0.4% to $123.54 on volume of 307,578,749 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) rose 8.1% to $0.3343 on vol...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
2024-06-28 07:00:08 ET Stephanie Davis from Barclays issued a price target of $5.50 for ACCD on 2024-06-28 05:31:00. The adjusted price target was set to $5.50. At the time of the announcement, ACCD was trading at $6.39. The overall price target consensus is at $19.22 wi...